US: Aetna divests Medicare business seeking CVS merger approval

Aetna announced plans on Thursday, September 27, to sell its Medicare prescription-drug business to WellCare Health Plans, a key step towards gaining regulator approval for its US$67.5 billion merger with CVS.

Although financial terms of the deal weren’t disclosed, in a securities filing, Aetna stated that the “purchase price is not material” to the company. The divestiture of the Medicare Part D to WellCare may help resolve objections to the CVS-Aetna deal from US antitrust regulators.

The company stated in the filing that, “Aetna believes the divestiture is a significant step toward completing the DOJ’s (Department of Justice) review.”

WellCare, a smaller health insurer that’s based in Tampa, Florida, has been using deals to fuel its expansion. The company completed a US$2.5 billion deal for the health insurer Meridian in early September, adding about 1.1 million insurance customers to its base of 4.4 million members.

Full Content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.

Please sign in or join us
to access premium content!